Clinical trial ACTRN12623000878673
Status: Recruiting (according to the registry)Phase not statedLatest change: Source: ANZCTR (Australia, New Zealand) (via WHO ICTRP)
What's on this page?
This record’s status may be out of date
The trial was registered in August 16, 2023 and still shows as "recruiting" in the registry. Status information in other countries’ registries is often not updated; the trial may have ended or stopped. For current information, check the record itself.
Information in the record
Original title: Preliminary assessment of the anti-inflammatory effects of THC and CBD in cancer patients.
- Record number
- ACTRN12623000878673
- Registry
- ANZCTR (Australia, New Zealand) (via WHO ICTRP)
- Status
- Recruiting (according to the registry)
- Type and phase
- Clinical trial, phase not stated
- Participants
- Target: 30
- Condition (as registered)
- Cancer, Cancer - Any cancer
- Countries
- Australia
- Topic in the guide
- Cancer Treatment
Timeline
According to the ANZCTR (Australia, New Zealand) (via WHO ICTRP) record. Future dates are the investigator’s estimates and may change.
- Registration: August 16, 2023
History
We check the record once a month via WHO ICTRP; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Cancer Treatment: guide page · Thinking of taking part? Which specialist to see